Cargando…

Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15

Background and Aims: Yunnan has been one of the provinces most afflicted by illicit drug use in China. However, there have been few systematic studies on the prevalence of illicit drug use in the area. Method: Using data on illicit drug users registered in the police system, this study aims to estim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guanbai, Jiang, Heng, Shen, Jiucheng, Wen, Pinyuan, Liu, Xuebing, Hao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010540/
https://www.ncbi.nlm.nih.gov/pubmed/29962974
http://dx.doi.org/10.3389/fpsyt.2018.00256
_version_ 1783333601645953024
author Zhang, Guanbai
Jiang, Heng
Shen, Jiucheng
Wen, Pinyuan
Liu, Xuebing
Hao, Wei
author_facet Zhang, Guanbai
Jiang, Heng
Shen, Jiucheng
Wen, Pinyuan
Liu, Xuebing
Hao, Wei
author_sort Zhang, Guanbai
collection PubMed
description Background and Aims: Yunnan has been one of the provinces most afflicted by illicit drug use in China. However, there have been few systematic studies on the prevalence of illicit drug use in the area. Method: Using data on illicit drug users registered in the police system, this study aims to estimate the population size of illicit drug users and the annual prevalence of drug use in Yunnan from 2011 to 2015 using Zelterman's capture-recapture method. Results: In the 15–64 year-old population, the estimated prevalence rate of any illicit drug use was 0.81% (0.76–0.86%) in 2011 and 0.94% (0.90–0.98%) in 2014, representing a significant increase. The prevalence rate of heroin use decreased from 0.67% (0.63–0.73%) in 2011 to 0.57% (0.53–0.61%) in 2015, while the prevalence rate of methamphetamine use doubled from 0.20% (0.17–0.24%) in 2011 to 0.48% (0.46–0.50%) in 2015. The mean age of the 141,702 identified illicit drug users in Yunnan from 2011 to 2015 was 32.2 years, and the majority were male, low educated, and peasants; nearly half were single and ethnic minorities. The ratio of the number of identified illicit drug users to the number of hidden users increased from 1:12 in 2011 to 1:5 in 2015. Conclusion: The prevalence of illicit drug use in Yunnan has been increasing. Although the prevalence of heroin use decreased, methamphetamine use increased dramatically from 2011 to 2015. Preventive strategies that are more effective in reducing illicit drug use are urgently needed in Yunnan.
format Online
Article
Text
id pubmed-6010540
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60105402018-06-29 Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15 Zhang, Guanbai Jiang, Heng Shen, Jiucheng Wen, Pinyuan Liu, Xuebing Hao, Wei Front Psychiatry Psychiatry Background and Aims: Yunnan has been one of the provinces most afflicted by illicit drug use in China. However, there have been few systematic studies on the prevalence of illicit drug use in the area. Method: Using data on illicit drug users registered in the police system, this study aims to estimate the population size of illicit drug users and the annual prevalence of drug use in Yunnan from 2011 to 2015 using Zelterman's capture-recapture method. Results: In the 15–64 year-old population, the estimated prevalence rate of any illicit drug use was 0.81% (0.76–0.86%) in 2011 and 0.94% (0.90–0.98%) in 2014, representing a significant increase. The prevalence rate of heroin use decreased from 0.67% (0.63–0.73%) in 2011 to 0.57% (0.53–0.61%) in 2015, while the prevalence rate of methamphetamine use doubled from 0.20% (0.17–0.24%) in 2011 to 0.48% (0.46–0.50%) in 2015. The mean age of the 141,702 identified illicit drug users in Yunnan from 2011 to 2015 was 32.2 years, and the majority were male, low educated, and peasants; nearly half were single and ethnic minorities. The ratio of the number of identified illicit drug users to the number of hidden users increased from 1:12 in 2011 to 1:5 in 2015. Conclusion: The prevalence of illicit drug use in Yunnan has been increasing. Although the prevalence of heroin use decreased, methamphetamine use increased dramatically from 2011 to 2015. Preventive strategies that are more effective in reducing illicit drug use are urgently needed in Yunnan. Frontiers Media S.A. 2018-06-14 /pmc/articles/PMC6010540/ /pubmed/29962974 http://dx.doi.org/10.3389/fpsyt.2018.00256 Text en Copyright © 2018 Zhang, Jiang, Shen, Wen, Liu and Hao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Zhang, Guanbai
Jiang, Heng
Shen, Jiucheng
Wen, Pinyuan
Liu, Xuebing
Hao, Wei
Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15
title Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15
title_full Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15
title_fullStr Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15
title_full_unstemmed Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15
title_short Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011–15
title_sort estimating prevalence of illicit drug use in yunnan, china, 2011–15
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010540/
https://www.ncbi.nlm.nih.gov/pubmed/29962974
http://dx.doi.org/10.3389/fpsyt.2018.00256
work_keys_str_mv AT zhangguanbai estimatingprevalenceofillicitdruguseinyunnanchina201115
AT jiangheng estimatingprevalenceofillicitdruguseinyunnanchina201115
AT shenjiucheng estimatingprevalenceofillicitdruguseinyunnanchina201115
AT wenpinyuan estimatingprevalenceofillicitdruguseinyunnanchina201115
AT liuxuebing estimatingprevalenceofillicitdruguseinyunnanchina201115
AT haowei estimatingprevalenceofillicitdruguseinyunnanchina201115